Having a word “on the tip of the tongue” has happened to all of us. Behind this everyday phenomenon lie complex brain ...
制药公司Cingulate Inc.(特拉华州注册)近日宣布,其首席执行官兼董事长Shane Schaffer的相关指控已被撤销。该法律事件最初于2024年10月4日披露,并于2025年1月28日得到解决。这一信息于周一通过向美国证券交易委员会提交的8-K表格公布。根据InvestingPro数据显示,该公司股票在过去一年下跌超过71%,但仍保持7.35的强劲流动比率。
Cingulate Inc. (NASDAQ: CING )是一家市值1640万美元的微型制药公司,专注于中枢神经系统 (CNS)治疗药物的开发。该公司宣布对其高管薪酬结构进行调整。过去一年,公司股价暴跌超过90%,但在过去六个月里已显示出复苏迹象,上涨了15%。
In a recent development, Cingulate Inc., a Delaware-incorporated pharmaceutical company, announced the dismissal of charges ...
Stock analysts at HC Wainwright issued their FY2025 earnings per share estimates for shares of Cingulate in a research note issued to investors on Thursday, January 30th. HC Wainwright analyst R.
H.C. Wainwright lifted its price target on shares of Cingulate (NASDAQ: CING) to $20.00, a significant increase from the previous target of $8.00. The firm has maintained a Buy rating on the stock, ...
北京时间2025年02月05日02时08分,美国OTC市场Ampio Pharmaceuticals Inc(AMPE.us)股票出现波动,股价急速 拉升 376.19%。截至发稿,该股报0.010美元/股,成交量444股, 换手率 0.04%,振幅0.00%。
Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...
H.C. Wainwright raised the firm’s price target on Cingulate (CING) to $20 from $8 and keeps a Buy rating on the shares to reflect the recent ...